This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Delivered as Hybrid Event from September 20-30, 2021
Live In-Person Experience Delivered September 20-23Boston Convention and Exhibition Center

Amanda Haas
Business Development Manager, Gene Editing Therapeutics at Agilent Technologies


Amanda Haas is a business Development Manager at Agilent Technologies focused on gene editing therapeutics. Prior to joining Agilent, Amanda spent the past 15 years working in R&D and product management contributing to research projects and new product development in multiple areas across RNA interference and CRISPR-Cas9 genome engineering. She received her degree in Chemistry and Religion at The University of Miami in 2003.

Agenda Sessions

  • ROOM 205C: Gram-Scale Good Manufacturing Practice (GMP) Single Guide RNA for CRISPR-based Gene Editing